Tus kws kho mob
QP22-20 Pharmacy Benefit Exclusion for Tepezza TM
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 12, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1611 - 1620 ntawm 4179
Tus kws kho mob
QP16-20 Pharmacy Benefit Exclusion for Padcev TM and Enhertu ®
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP21-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Baclofen
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP18-20 Pharmacy Benefit Exclusion for Calcipotriene-Betamethasone Dipropionate Suspension 0.005-0.064% (authorized generic (AG) of Taclonex suspension)
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 12, 2020
Tus kws kho mob
P9-20 MHCP Prenatal Service Third Party Liability Change
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P12-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P10-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective April 6, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P13-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers- eviCore Healthcare Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2020
Tus kws kho mob
P11-20 Updated Bulletin: Commercial Inpatient Admission Notification Process Changes
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2020
Tus kws kho mob
2020 February Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2020